137 related articles for article (PubMed ID: 29319843)
61. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?
Lodise TP; Drusano GL; Zasowski E; Dihmess A; Lazariu V; Cosler L; McNutt LA
Clin Infect Dis; 2014 Sep; 59(5):666-75. PubMed ID: 24867791
[TBL] [Abstract][Full Text] [Related]
62. Establishment of an AUC
Chavada R; Ghosh N; Sandaradura I; Maley M; Van Hal SJ
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242672
[TBL] [Abstract][Full Text] [Related]
63. Vancomycin dosage in overweight and obese children.
Miller M; Miller JL; Hagemann TM; Harrison D; Chavez-Bueno S; Johnson PN
Am J Health Syst Pharm; 2011 Nov; 68(21):2062-8. PubMed ID: 22011985
[TBL] [Abstract][Full Text] [Related]
64. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
[TBL] [Abstract][Full Text] [Related]
65. Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
Hamilton LA; Christopher Wood G; Magnotti LJ; Croce MA; Martin JB; Swanson JM; Boucher BA; Fabian TC
J Trauma Acute Care Surg; 2012 Jun; 72(6):1478-83. PubMed ID: 22695410
[TBL] [Abstract][Full Text] [Related]
66. Design and Implementation of a Novel Web-Based E-Learning Tool for Education of Health Professionals on the Antibiotic Vancomycin.
Bond SE; Crowther SP; Adhikari S; Chubaty AJ; Yu P; Borchard JP; Boutlis CS; Yeo WW; Miyakis S
J Med Internet Res; 2017 Mar; 19(3):e93. PubMed ID: 28360025
[TBL] [Abstract][Full Text] [Related]
67. Early Administration of Adjuvant β-Lactam Therapy in Combination with Vancomycin among Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: A Retrospective, Multicenter Analysis.
Casapao AM; Jacobs DM; Bowers DR; Beyda ND; Dilworth TJ;
Pharmacotherapy; 2017 Nov; 37(11):1347-1356. PubMed ID: 28949410
[TBL] [Abstract][Full Text] [Related]
68. Pharmacokinetics of glycopeptide antibiotics in children.
Ito H; Shime N; Kosaka T
J Infect Chemother; 2013 Apr; 19(2):352-5. PubMed ID: 22872188
[TBL] [Abstract][Full Text] [Related]
69. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
[TBL] [Abstract][Full Text] [Related]
70. A randomized controlled trial of a vancomycin loading dose in children.
Demirjian A; Finkelstein Y; Nava-Ocampo A; Arnold A; Jones S; Monuteaux M; Sandora TJ; Patterson A; Harper MB
Pediatr Infect Dis J; 2013 Nov; 32(11):1217-23. PubMed ID: 23817340
[TBL] [Abstract][Full Text] [Related]
71. Best alternative to vancomycin for serious methicillin-resistant Staphylococcus aureus infections: let's just say it.
Bush LM
Clin Infect Dis; 2011 Nov; 53(9):965-6. PubMed ID: 21880584
[No Abstract] [Full Text] [Related]
72. Prospective evaluation of vancomycin therapeutic usage and trough levels monitoring.
Kabbara WK; El-Khoury G; Chamas NR
J Infect Dev Ctries; 2018 Nov; 12(11):978-984. PubMed ID: 32012127
[TBL] [Abstract][Full Text] [Related]
73. Vancomycin: we can't get there from here.
Patel N; Pai MP; Rodvold KA; Lomaestro B; Drusano GL; Lodise TP
Clin Infect Dis; 2011 Apr; 52(8):969-74. PubMed ID: 21460308
[TBL] [Abstract][Full Text] [Related]
74. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus infection in cystic fibrosis.
Zobell JT; Epps KL; Young DC; Montague M; Olson J; Ampofo K; Chin MJ; Marshall BC; Dasenbrook E
Pediatr Pulmonol; 2015 Jun; 50(6):552-9. PubMed ID: 25559432
[TBL] [Abstract][Full Text] [Related]
75. Eradication of methicillin resistant Staphylococcus aureus detected for the first time in cystic fibrosis: A single center observational study.
Kappler M; Nagel F; Feilcke M; Kröner C; Pawlita I; Naehrig S; Ripper J; Hengst M; von Both U; Forstner M; Hector A; Griese M
Pediatr Pulmonol; 2016 Oct; 51(10):1010-1019. PubMed ID: 27378061
[TBL] [Abstract][Full Text] [Related]
76. In vivo antibacterial activity and pharmacological properties of the membrane-active glycopeptide antibiotic YV11455.
Yarlagadda V; Konai MM; Manjunath GB; Prakash RG; Mani B; Paramanandham K; Ranjan SB; Ravikumar R; Chakraborty SP; Roy S; Haldar J
Int J Antimicrob Agents; 2015 Jun; 45(6):627-34. PubMed ID: 25900818
[TBL] [Abstract][Full Text] [Related]
77. Activity of Tedizolid in Methicillin-Resistant Staphylococcus aureus Experimental Foreign Body-Associated Osteomyelitis.
Park KH; Greenwood-Quaintance KE; Mandrekar J; Patel R
Antimicrob Agents Chemother; 2016 Nov; 60(11):6568-6572. PubMed ID: 27550347
[TBL] [Abstract][Full Text] [Related]
78. Evaluation of the vancomycin dosage regimen based on serum creatinine used in the neonatal intensive care unit.
Irikura M; Fujiyama A; Saita F; Fukushima S; Kitaoka H; Fukuda T; Kawase A; Kondo Y; Ishitsuka Y; Kondo G; Maeda T; Yukawa E; Irie T
Pediatr Int; 2011 Dec; 53(6):1038-44. PubMed ID: 21810150
[TBL] [Abstract][Full Text] [Related]
79. An investigation of vancomycin minimum inhibitory concentration creep among methicillin-resistant Staphylococcus aureus strains isolated from pediatric patients and healthy children in Northern Taiwan.
Chang CN; Lo WT; Chan MC; Yu CM; Wang CC
J Microbiol Immunol Infect; 2017 Jun; 50(3):362-369. PubMed ID: 26297168
[TBL] [Abstract][Full Text] [Related]
80. Vancomycin population pharmacokinetics in neonates.
de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
